真人做爰48姿势视图片|少妇真人直播免费视频|日本真人做爰A片|真人裸体做爰视频|真人与拘做爰视频免费观看|真人与拘做受免费视频一

穿孔素1(PRF1)多克隆抗體

Polyclonal Antibody to Perforin 1 (PRF1)

FLH2; HPLH2; P1; PFP; Pore Forming Protein; Cytolysin; Lymphocyte pore-forming protein

  • 穿孔素1(PRF1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)多克隆抗體 產(chǎn)品包裝(模擬)
  • 穿孔素1(PRF1)多克隆抗體 IHC圖
  • PAB317Ra01.jpg Western Blot; Samples: Lane1: Rat Lung lysate; Lane2: Mouse Lung lysate; Primary Ab: 1μg/ml Rabbit Anti-Rat PRF1 Antibody Second Ab: 0.2μg/ml HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
  • Certificate 通過ISO 9001、ISO 13485質(zhì)量體系認證

特異性

該抗體是針對PRF1的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別PRF1。

用法

Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.

儲存

經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。

穩(wěn)定性

熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。

贈品

相關(guān)產(chǎn)品

編號 適用物種:Rattus norvegicus (Rat,大鼠) 應(yīng)用(僅供研究使用,不用于臨床診斷!)
RPB317Ra01 穿孔素1(PRF1)重組蛋白 Positive Control; Immunogen; SDS-PAGE; WB.
APB317Ra01 穿孔素1(PRF1)活性蛋白 Cell?culture;?Activity?Assays.
PAB317Ra01 穿孔素1(PRF1)多克隆抗體 WB; IHC; ICC; IP.
MAB317Ra21 穿孔素1(PRF1)單克隆抗體 WB; IHC; ICC; IP.
SEB317Ra 穿孔素1(PRF1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) Enzyme-linked immunosorbent assay for Antigen Detection.
LMB317Ra 穿孔素1(PRF1)等多因子檢測試劑盒(流式熒光發(fā)光法) FLIA Kit for Antigen Detection.

參考文獻

雜志 參考文獻
Diagnostic Microbiology and Infectious Disease Granzyme B as a diagnostic marker of tuberculosis in patients with and without HIV coinfection [Pubmed:26915636]
FASEB?JOURNAL The immunoregulatory effects of CD8 T-cell–derived perforin on diet-induced nonalcoholic steatohepatitis [Pubmed: 30951375]
Theranostics A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors [Pubmed: 31695790]
Mol Immunol CD317 mediates immunocytolysis resistance by RICH2/cytoskeleton-dependent membrane protection [Pubmed: 33223223]
INVESTIGATIONAL NEW DRUGS Dual-function chimeric antigen receptor T cells targeting c-Met and PD-1 exhibit potent anti-tumor efficacy in solid tumors [Pubmed: 32772342]
Am J Transl Res Combined treatment with epigenetic agents enhances anti-tumor activity of T cells by upregulating the ACRBP expression in hepatocellular carcinoma [34377237]
Nat Biomed Eng Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy [34873307]
J Exp Med Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion [Pubmed:35061012]
留言咨詢
铁力市| 兴海县| 车险| 丽水市| 隆德县| 金溪县| 习水县| 同心县| 凤庆县| 呈贡县| 临沧市| 灵石县| 边坝县| 澳门| 阜南县| 临沂市| 蓝田县| 都兰县| 揭阳市| 皮山县| 荣成市| 柳河县| 武宣县| 廊坊市| 三江| 蓝山县| 鹤壁市| 靖远县| 巫溪县| 抚州市| 陇西县| 丰原市| 林西县| 杭锦后旗| 元氏县| 高邑县| 汶上县| 靖州| 铜山县| 江安县| 河间市|